AusPAR: Brolucizumab (rbe)

Australian Public Assessment Report

AusPAR

AusPAR: Brolucizumab (rbe) [PDF, 762.42 KB]

AusPAR: Brolucizumab (rbe) [Word, 852.73 KB]

Attachment: Product Information for Brolucizumab (rbe) [PDF, 203.7 KB]

Attachment: Product Information for Brolucizumab (rbe) [Word, 99.01 KB]

Device/Product Name

Beovu

Active ingredients

Brolucizumab (rbe)

AusPAR Date

14 April 2020

Published

16 April 2020

Submission Number

PM-2019-00106-1-5

Submission Type

New biological entity

Decision

Approved